Target (CBDY) Other financing activities (2020 - 2025)
Target (CBDY) reported Other financing activities of $19.0 for Q4 2025, down 99.84% year-over-year from $12137.0 in Q4 2024, and down 99.69% quarter-over-quarter from $6047.0 in Q3 2025.
Target (CBDY) Other financing activities (2020 - 2025) Analysis & Trends
Target (CBDY) has 6 years of Other financing activities data on file, last reported at $19.0 in Q4 2025.
- Other financing activities for Q4 2025 came in at $19.0, down 99.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $29744.0 (down 39.29% YoY), and the FY2025 annual result was $29744.0, down 39.29% from the prior year.
- Other financing activities fell to $19.0 in Q4 2025 per CBDY's latest filing, from $6047.0 in the prior quarter.
- Over five years, Other financing activities peaked at $13511.0 in Q2 2021 and troughed at $19.0 in Q4 2025.
- A 5-year average of $11632.8 and a median of $12421.0 in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2025: Other financing activities surged 110.16% in 2021, then tumbled 99.84% in 2025.
- A 5-year view of Other financing activities shows it stood at $12717.0 in 2021, then dropped by 1.7% to $12501.0 in 2022, then retreated by 1.98% to $12254.0 in 2023, then decreased by 0.95% to $12137.0 in 2024, then plunged by 99.84% to $19.0 in 2025.
- Business Quant data shows CBDY's Other financing activities at $19.0 in Q4 2025, $6047.0 in Q3 2025, and $11989.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Target | - | - | 191,787.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.00 |
| Dec 31, 2025 | 19.00 |
| Sep 30, 2025 | 6,047.00 |
| Sep 30, 2025 | 6,047.00 |
| Jun 30, 2025 | 11,989.00 |
| Jun 30, 2025 | 11,989.00 |
| Mar 31, 2025 | 11,689.00 |
| Mar 31, 2025 | 11,689.00 |
| Dec 31, 2024 | 12,137.00 |
| Dec 31, 2024 | 12,137.00 |
| Sep 30, 2024 | 12,300.00 |
| Sep 30, 2024 | 12,300.00 |
| Jun 30, 2024 | 12,121.00 |
| Jun 30, 2024 | 12,121.00 |
| Mar 31, 2024 | 12,439.00 |
| Mar 31, 2024 | 12,439.00 |
| Dec 31, 2023 | 12,254.00 |
| Dec 31, 2023 | 12,254.00 |
| Sep 30, 2023 | 12,509.00 |
| Sep 30, 2023 | 12,509.00 |